Pregnancy, breastfeeding, and other considerations regarding Aimovig
Aimovig and Pregnancy or Breastfeeding: What You Need to Know
Aimovig, a brand-name injection used to prevent migraine headaches, is not currently established as safe for use during pregnancy or breastfeeding. While there is no known evidence that Aimovig harms an unborn baby or passes into breast milk, the safety and efficacy in pregnant and pediatric patients have not been fully studied.
Medical sources highlight the need to inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding before starting Aimovig. The specifics regarding Aimovig's excretion in breast milk and infant safety remain unknown.
Official medication guides advise caution and consultation with healthcare providers before using Aimovig during pregnancy or lactation. Safer alternatives with more studied safety profiles in these populations may be considered for migraine prevention.
If you are pregnant or considering pregnancy, it is recommended to consult a doctor to discuss the safety of using Aimovig. More studies are needed to confirm the safety of Aimovig during breastfeeding.
For more comprehensive information about Aimovig, please refer to the provided article. If you are currently using Aimovig and are pregnant or breastfeeding, or if you have any concerns about the drug's safety, contact the Aimovig pregnancy registry at 833-244-4083, this site, or your doctor.
Always consult a doctor or healthcare professional before taking any medication. The drug information provided is subject to change and should not be used as a substitute for professional medical advice.
[1] [Source 1] [2] [Source 2] [3] [Source 3] [4] [Source 4]
